New funding to RESET Diabetes research You are here:HomeNewsroomNews New funding to RESET Diabetes research 26 Apr 2023 Congratulations to Dr Jennifer Snaith, St Vincent’s Endocrinologist and Garvan PhD scholar, who was recently awarded the inaugural Rebecca Davies Clinician Research Fellowship worth $150,000 by JDRF, an international organisation dedicated to supporting type 1 diabetes research. Semaglutide, a medication that replicates a gut hormone, has been shown to reduce risk of heart disease, improve weight and blood sugar in people living type 2 diabetes, and Dr Snaith’s research will explore its efficacy in reducing the risk of cardiovascular disease in people living with type 1 diabetes. “Heart disease is the leading cause of premature death in type 1 diabetes. There is an urgent need to identify treatments that address this and other issues including weight, blood sugar control, and unhealthy body composition”, said Dr Snaith. The RESET study will be the first to determine if this simple once a week injection improves metabolism and heart health in people living with type 1 diabetes. Concurrently the team will conduct an in-depth investigation of the nature of gut hormones in type 1 diabetes. The clinical trial will be conducted through the Garvan Institute of Medical Research. Volunteer recruitment will commence towards the end of 2023. Dr Jennifer Snaith